精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

NICE指南：患有复杂精神病的成年人的康复 2020

2020-11-06 国家卫生和护理研究所（NICE） NICE

精神病

本指南涵盖患有复杂精神病的成年人的心理健康康复。 它旨在确保人们在需要时能够康复，并为长期康复提倡积极的态度。 它包括有关组织康复服务，评估和护理计划，提供计划和干预措施以及满足人们身体保健需求的建议

中文标题：

NICE指南：患有复杂精神病的成年人的康复 2020

英文标题：

Rehabilitation for adults with complex psychosis

发布机构：

国家卫生和护理研究所（NICE）

发布日期：

2020-11-06

简要介绍：

本指南涵盖患有复杂精神病的成年人的心理健康康复。 它旨在确保人们在需要时能够康复，并为长期康复提倡积极的态度。 它包括有关组织康复服务，评估和护理计划，提供计划和干预措施以及满足人们身体保健需求的建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6f0b01c002056a79, title=NICE指南：患有复杂精神病的成年人的康复 2020, enTitle=Rehabilitation for adults with complex psychosis, guiderFrom=NICE, authorId=0, author=, summary=本指南涵盖患有复杂精神病的成年人的心理健康康复。 它旨在确保人们在需要时能够康复，并为长期康复提倡积极的态度。 它包括有关组织康复服务，评估和护理计划，提供计划和干预措施以及满足人们身体保健需求的建议, cover=, journalId=0, articlesId=null, associationId=1435, associationName=国家卫生和护理研究所（NICE）, associationIntro=, copyright=0, guiderPublishedTime=Fri Nov 06 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">本指南涵盖患有复杂精神病的成年人的心理健康康复。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="1">它旨在确保人们在需要时能够康复，并为长期康复提倡积极的态度。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="2">它包括有关组织康复服务，评估和护理计划，提供计划和干预措施以及满足人们身体保健需求的建议。</span></span></p>, tagList=[TagDto(tagId=624, tagName=精神病)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6369, appHits=104, showAppHits=0, pcHits=496, showPcHits=6265, likes=2, shares=13, comments=7, approvalStatus=1, publishedTime=Sun Feb 14 09:55:34 CST 2021, publishedTimeString=2020-11-06, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Sat Feb 13 19:46:22 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Wed Jan 03 07:42:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1179356, encodeId=d2d011e9356a7, content=好文章，有价值。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf32513404, createdName=124c40bbm69暂无昵称, createdTime=Fri Dec 31 16:23:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966004, encodeId=03a5966004fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210516/0f7f5a59d50e4b82912a2886fff6eb76/26bf8823da8c4b27a12d13ee7efc948e.jpg, createdBy=b04a5502492, createdName=ms7000001834270833, createdTime=Sun May 16 11:14:24 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965733, encodeId=235b965e33e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Fri May 14 23:34:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947818, encodeId=e93294e8187e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1UrfvicTAZqcYibe0PIGnJKtvLQCH0ryntjb3oqjpT2EPibqBko7c0TSuFZ2ydkWjaAib2FS3Nur8trQFchHIcD22w/132, createdBy=5b9d5316196, createdName=Ellie, createdTime=Sat Mar 13 10:19:18 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947684, encodeId=ea2594e6844b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:56:19 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-12-31 124c40bbm69暂无昵称

    好文章，有价值。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1179356, encodeId=d2d011e9356a7, content=好文章，有价值。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf32513404, createdName=124c40bbm69暂无昵称, createdTime=Fri Dec 31 16:23:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966004, encodeId=03a5966004fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210516/0f7f5a59d50e4b82912a2886fff6eb76/26bf8823da8c4b27a12d13ee7efc948e.jpg, createdBy=b04a5502492, createdName=ms7000001834270833, createdTime=Sun May 16 11:14:24 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965733, encodeId=235b965e33e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Fri May 14 23:34:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947818, encodeId=e93294e8187e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1UrfvicTAZqcYibe0PIGnJKtvLQCH0ryntjb3oqjpT2EPibqBko7c0TSuFZ2ydkWjaAib2FS3Nur8trQFchHIcD22w/132, createdBy=5b9d5316196, createdName=Ellie, createdTime=Sat Mar 13 10:19:18 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947684, encodeId=ea2594e6844b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:56:19 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-05-16 ms7000001834270833

    好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1179356, encodeId=d2d011e9356a7, content=好文章，有价值。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf32513404, createdName=124c40bbm69暂无昵称, createdTime=Fri Dec 31 16:23:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966004, encodeId=03a5966004fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210516/0f7f5a59d50e4b82912a2886fff6eb76/26bf8823da8c4b27a12d13ee7efc948e.jpg, createdBy=b04a5502492, createdName=ms7000001834270833, createdTime=Sun May 16 11:14:24 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965733, encodeId=235b965e33e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Fri May 14 23:34:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947818, encodeId=e93294e8187e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1UrfvicTAZqcYibe0PIGnJKtvLQCH0ryntjb3oqjpT2EPibqBko7c0TSuFZ2ydkWjaAib2FS3Nur8trQFchHIcD22w/132, createdBy=5b9d5316196, createdName=Ellie, createdTime=Sat Mar 13 10:19:18 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947684, encodeId=ea2594e6844b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:56:19 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-05-14 ms1000000580800231

    好文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1179356, encodeId=d2d011e9356a7, content=好文章，有价值。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf32513404, createdName=124c40bbm69暂无昵称, createdTime=Fri Dec 31 16:23:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966004, encodeId=03a5966004fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210516/0f7f5a59d50e4b82912a2886fff6eb76/26bf8823da8c4b27a12d13ee7efc948e.jpg, createdBy=b04a5502492, createdName=ms7000001834270833, createdTime=Sun May 16 11:14:24 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965733, encodeId=235b965e33e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Fri May 14 23:34:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947818, encodeId=e93294e8187e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1UrfvicTAZqcYibe0PIGnJKtvLQCH0ryntjb3oqjpT2EPibqBko7c0TSuFZ2ydkWjaAib2FS3Nur8trQFchHIcD22w/132, createdBy=5b9d5316196, createdName=Ellie, createdTime=Sat Mar 13 10:19:18 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947684, encodeId=ea2594e6844b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:56:19 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-03-13 Ellie

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1179356, encodeId=d2d011e9356a7, content=好文章，有价值。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf32513404, createdName=124c40bbm69暂无昵称, createdTime=Fri Dec 31 16:23:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966004, encodeId=03a5966004fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210516/0f7f5a59d50e4b82912a2886fff6eb76/26bf8823da8c4b27a12d13ee7efc948e.jpg, createdBy=b04a5502492, createdName=ms7000001834270833, createdTime=Sun May 16 11:14:24 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965733, encodeId=235b965e33e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Fri May 14 23:34:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947818, encodeId=e93294e8187e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1UrfvicTAZqcYibe0PIGnJKtvLQCH0ryntjb3oqjpT2EPibqBko7c0TSuFZ2ydkWjaAib2FS3Nur8trQFchHIcD22w/132, createdBy=5b9d5316196, createdName=Ellie, createdTime=Sat Mar 13 10:19:18 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947684, encodeId=ea2594e6844b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:56:19 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-03-12 jyzxjiangqin

    好指南！

    0

相关指南

2020 NICE指南：成人复杂精神病的康复治疗（NG.181）

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2020-08-19

抗精神病药物的临床试验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-31

2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点

美国急诊医师学会(ACEP,American College of Emergency Physicians) · 2017-04-01

2016 亚太地区近期发作的精神病患者的最佳照护建议

国外精神科相关专家小组（统称） · 2016-04-11

2016 BAP指南：精神病和抗精神病药物治疗相关性体重增加，代谢紊乱和心血管风险的管理

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2016-05-04